Pterygium Surgery by Conjuctival Autograft with Autologous Blood Fixation versus Fibrin Glue

doi:10.5281/zenodo.13141122

International Journal of Medical and Pharmaceutical Research

2024, Volume-5, Issue-4 doi: 10.5281/zenodo.13141122

Original Research Article

Pterygium Surgery by Conjuctival Autograft with Autologous Blood Fixation versus Fibrin Glue

Dr.TruptiM.Solu ,Dr.AkankshaRangari

DOI : 10.5281/zenodo.13141122

Abstract

Aims and Objective: To compare the outcome between autologous blood and fibrin glue fixated conjunctival autograft in pterygium surgery. Methods and Materials: A retrospective comparative study was carried out in 40 eyes that had a primary nasal pterygium excision in tertiary hospital in South Gujarat from January 2023 to June 2023. The patients were divided into 2 groups, in Group 1 autograft was attached with autologous blood and in Group 2 with fibrin glue. Groups were compared for surgical time, postoperative discomfort and recurrence. Result: The average surgical time was least with glue i.e 37.5 min, and 45.2 min for without glue. The postoperative discomfort was minimal in both groups. No recurrence was found in both groups till 6months follow up. Conclusion: The fibrin glue is most effective method for attaching autograft with least surgical time and postoperative discomfort. Autologous blood is an effective alternative easily available, economical than glue with less surgical time and postoperative discomfort.

Recommended Articles

Volume-5, Issue-4

Downloads

Download PDF pdf

Download XML

Citations

1479 Views

434 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.